Is Breyna still in shortage in 2026? Get the latest update on Breyna availability, pricing, alternatives, and how to find this asthma and COPD inhaler in stock.
If you rely on Breyna (Budesonide/Formoterol) for your asthma or COPD, you've probably noticed it isn't always easy to find at the pharmacy. Reports of spotty availability have been circulating since Breyna first launched in 2023 — so what's the situation in 2026?
This article gives you the latest update on Breyna's supply status, what's driving availability issues, what it costs now, and what you can do if you can't find it.
As of early 2026, Breyna is not on the FDA's official drug shortage list. That's the good news. However, patients in some regions continue to experience intermittent difficulty finding it at their local pharmacies.
This isn't a full-blown shortage in the way some medications (like certain ADHD or GLP-1 drugs) have experienced. Instead, it's more of a supply-demand imbalance — there's enough Breyna being manufactured overall, but distribution is uneven. Some pharmacies have it on the shelf; others don't.
Several factors contribute to the ongoing availability challenges:
Breyna's launch as the first and most affordable generic of Symbicort made it an instant hit. Millions of asthma and COPD patients — and their prescribers — quickly switched. This created demand that sometimes exceeds what wholesalers allocate to individual pharmacies.
Metered-dose inhalers like Breyna require specialized production facilities. The aerosol filling, canister assembly, and actuator manufacturing all need to meet strict FDA standards. Any production hiccup can affect supply for weeks.
Major drug distributors (McKesson, Cardinal Health, AmerisourceBergen) use allocation systems that limit how much of a high-demand drug each pharmacy can order. This is designed to spread supply fairly, but it means some pharmacies get shorted while others may have extra inventory.
Breyna's parent drug, Symbicort, experienced its own intermittent shortages in 2023 and 2024, driven by supply chain challenges and increased respiratory illness seasons. Some of that supply chain instability has carried over to the generic market.
Cost is a big part of the picture. Here's what you can expect:
For a detailed breakdown, check out how to save money on Breyna in 2026.
The generic inhaler market has been evolving. Here are some developments patients should know about:
If your usual pharmacy doesn't have Breyna, here's your game plan:
For more detailed strategies, see our full guide: How to find Breyna in stock near you.
The Breyna supply situation in 2026 is better than it was in 2023 and 2024, but it's not perfect. Regional availability gaps persist, and some patients still face the frustrating experience of being told their pharmacy doesn't have it.
The most important thing is to stay proactive: refill early, use tools like Medfinder, talk to your pharmacist, and keep your doctor in the loop if you're having consistent trouble getting your medication. You have more options than you might think — and none of them require going without treatment.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
